Researchers developed SPLICER, a gene editing tool that reduces amyloid-beta plaque in Alzheimer's mice.

Researchers at the University of Illinois Urbana-Champaign have developed a new gene editing tool called SPLICER that successfully reduced the formation of amyloid-beta plaque precursors in mice with Alzheimer's disease. SPLICER uses exon skipping, a method that could help treat diseases caused by toxic proteins, like muscular dystrophy and Huntington's disease. In tests, SPLICER reduced targeted gene segments by 25% with no off-target effects, showing promise for treating various genetic conditions.

3 months ago
4 Articles

Further Reading